Last reviewed · How we verify

Standard multimodal pain management regimen

Thomas L Bradbury · FDA-approved active Small molecule

A multimodal pain management regimen combines multiple analgesic agents and techniques with different mechanisms of action to provide synergistic pain relief.

A multimodal pain management regimen combines multiple analgesic agents and techniques with different mechanisms of action to provide synergistic pain relief. Used for Acute postoperative pain, Chronic pain conditions, Cancer pain.

At a glance

Generic nameStandard multimodal pain management regimen
SponsorThomas L Bradbury
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Standard multimodal pain management typically integrates opioids, non-opioid analgesics (such as NSAIDs or acetaminophen), adjuvant medications (such as gabapentinoids or antidepressants), and non-pharmacological interventions to target pain through multiple pathways simultaneously. This approach aims to optimize analgesia while reducing the required dose of any single agent, thereby minimizing adverse effects and improving overall pain control.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: